ORPHA:3309
Tetrasomy 5p syndrome
Also known as: Isochromosome 5p
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
58
33.9th percentile
Trials
0
Interventional, condition-specific
Researchers
373
Distinct authors in sample
Gene link
—
Readiness
1/6
Stages with a signal
Clinical definition (Orphanet)
Tetrasomy 5p is a rare chromosomal anomaly syndrome with variable principally characterized by , growth retardation/short stature, , , ventriculomegaly, hand and foot anomalies (e.g. clinodactyly, overlapping toes) and mosaic pigmentary skin changes. Patients may also present minor craniofacial features (incl. macrocephaly, upslanting palpebral fissures, hypertelorism, abnormal auricles, anteverted nasal tip, midface hypoplasia).
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0018028
- UMLS:C0795813
Additional Mondo synonyms (1)
tetrasomy type 5p
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
1/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
58 matched papers (16 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
58
58 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
58 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
16 in the last 10 years · high confidence · 33.9th percentile (publications denominator)
Phrase hits: 58 · MeSH hits: 0
Who's working on it?
373
Distinct author names in 58 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Liehr T3 papers · 2023
Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
Papers in Europe PMC - 02Bettio D2 papers · 2009Papers in Europe PMC
- 03Haferlach T2 papers · 2004Papers in Europe PMC
- 04Jordanova ES2 papers · 2007Papers in Europe PMC
- 05Panani AD2 papers · 2010
The Critical Care Department, Medical School of Athens University, Research Unit, "Evangelismos" Hospital, Athens, Greece. apanani@med.uoa.gr
Papers in Europe PMC - 06Sáenz-Rico B2 papers · 2023
Departamento de Estudios Educativos, Facultad de Educación, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Papers in Europe PMC - 07Schnittger S2 papers · 2004Papers in Europe PMC
- 08Schoch C2 papers · 2004
Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-University, Marchioninistrass 15, 81377 Munich, Germany. claudia.schoch@med3.med.uni-muenchen.de
Papers in Europe PMC - 09Abunaser SMA1 paper · 2025
Bahrain Oncology Center Laboratory, Bahrain Oncology Centre, Road 2835, Block 228, P.O. Box 24343, Busaiteen, Kingdom of Bahrain. Electronic address: suhaib.abunaser@rms.bh.
Papers in Europe PMC - 10Al-Rikabi A1 paper · 2019
Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Tetrasomy 5p syndrome" OR "Isochromosome 5p" OR "tetrasomy type 5p"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Tetrasomy 5p syndrome" OR "Isochromosome 5p" OR "tetrasomy type 5p" OR "partial trisomy/tetrasomy of the short arm of chromosome 5" OR "partial trisomy/tetrasomy of chromosome 5"
Recall-expansion terms: partial trisomy/tetrasomy of the short arm of chromosome 5, partial trisomy/tetrasomy of chromosome 5
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T22:49:09.664Z